Corinne Brillant
About
Corinne Brillant is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology.
According to data from OpenAlex, Corinne Brillant has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pathology and Forensic Medicine, 17 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Corinne Brillant's work include Lymphoma Diagnosis and Treatment (25 papers), Lung Cancer Treatments and Mutations (17 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Corinne Brillant is often cited by papers focused on Lymphoma Diagnosis and Treatment (25 papers), Lung Cancer Treatments and Mutations (17 papers) and CNS Lymphoma Diagnosis and Treatment (4 papers). Corinne Brillant collaborates with scholars based in Germany, Switzerland and Denmark. Corinne Brillant's co-authors include Andreas Engert, Volker Diehl, Andreas Engert, Nicole Skoetz, Ina Monsef, Andreas Draube, Nela Klein-González, Michael von Bergwelt‐Baildon, Martin Hellmich and Rolf‐Peter Müller and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
In The Last Decade
Corinne Brillant
30 papers receiving 1.1k citations
Peers
Corinne Brillant
Paul J. Bröckelmann Germany
Felicitas Hitz Switzerland
Beate Klimm Germany
Helen Goergen Germany
Rachel Pearce United Kingdom
Silvia Franceschetti Italy
Igor Aurer Croatia
Astrid Franke Germany
Marina Djurfeldt Canada
B. Lathan Germany
Citations per year, relative to Corinne Brillant Corinne Brillant (= 1×)
peers
Paul J. Bröckelmann
Countries citing papers authored by Corinne Brillant
Since
Specialization
Citations
This map shows the geographic impact of Corinne Brillant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corinne Brillant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corinne Brillant more than expected).
Fields of papers citing papers by Corinne Brillant
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Corinne Brillant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corinne Brillant. The network helps show where Corinne Brillant may publish in the future.
Co-authorship network of co-authors of Corinne Brillant
This figure shows the co-authorship network connecting the top 25 collaborators of Corinne Brillant. A scholar is included among the top collaborators of Corinne Brillant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corinne Brillant. Corinne Brillant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kreissl, Stefanie, Horst Mueller, Helen Goergen, et al.. (2016). Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group. The Lancet Oncology. 17(10). 1453–1462.
2.
Klimm, Beate, Corinne Brillant, Nicole Skoetz, et al.. (2012). The Effect of Specialized Cancer Treatment Centers on Treatment Efficacy in Hodgkin’s Lymphoma. Deutsches Ärzteblatt international. 109(51-52). 893–9.
3.
Herbst, Christine, Nicole Skoetz, Julia Bohlius, et al.. (2011). Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma. Cochrane Database of Systematic Reviews. CD007110–CD007110.
4.
Draube, Andreas, Nela Klein-González, Corinne Brillant, et al.. (2011). Dendritic Cell Based Tumor Vaccination in Prostate and Renal Cell Cancer: A Systematic Review and Meta-Analysis. PLoS ONE. 6(4). e18801–e18801.
5.
Bauer, K. H., Nicole Skoetz, Ina Monsef, Andreas Engert, & Corinne Brillant. (2011). Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma. Cochrane Database of Systematic Reviews. CD007941–CD007941.
6.
Terschüren, Claudia, et al.. (2010). Are patients with Hodgkin lymphoma and high-grade non-Hodgkin lymphoma in clinical therapy optimization protocols representative of these groups of patients in Germany?. Annals of Oncology. 21(10). 2045–2051.
7.
Bauer, K. H., Christine Herbst, Corinne Brillant, et al.. (2010). Eleventh Biannual Report of the Cochrane Haematological Malignancies Group: Focus on Hodgkin Lymphoma. JNCI Journal of the National Cancer Institute. 102(12). E1–E1.
8.
Brillant, Corinne, Guido Schwarzer, Julia Bohlius, et al.. (2009). HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL SUPPORT IN FIRST LINE TREATMENT OF AGGRESSIVE NON HODGKIN LYMPHOMA: RESULTS OF AN INDIVIDUAL PATIENT DATA META-ANALYSIS. IRIS Research product catalog (Sapienza University of Rome).
9.
Skoetz, Nicole, Olaf Weingart, Ina Monsef, et al.. (2009). Ninth Biannual Report of the Cochrane Haematological Malignancies Group--Focus on Hematopoietic Growth Factors. JNCI Journal of the National Cancer Institute. 101(9). E1–E1.
10.
Herbst, Christine, Corinne Brillant, Julia Bohlius, et al.. (2009). Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review. Haematologica. 95(3). 494–500.
11.
Brillant, Corinne, K. H. Bauer, Christine Herbst, et al.. (2009). Escalated BEACOPP Versus ABVD-Like Chemotherapy for Hodgkin Lymphoma Patients: a Cochrane Review.. Blood. 114(22). 3705–3705.
12.
Eich, Hans Theodor, Axel Goßmann, Andreas Engert, et al.. (2007). A Contribution to Solve the Problem of the Need for Consolidative Radiotherapy after Intensive Chemotherapy in Advanced Stages of Hodgkin's Lymphoma—Analysis of a Quality Control Program Initiated by the Radiotherapy Reference Center of the German Hodgkin Study Group (GHSG). International Journal of Radiation Oncology*Biology*Physics. 69(4). 1187–1192.
13.
Nogová, Lucia, Thorsten Reineke, Corinne Brillant, et al.. (2007). Lymphocyte-Predominant and Classical Hodgkin's Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group. Journal of Clinical Oncology. 26(3). 434–439.
14.
Nogová, Lucia, Thorsten Reineke, Hans Theodor Eich, et al.. (2005). Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG). Annals of Oncology. 16(10). 1683–1687.
15.
Eich, Hans Theodor, Uwe Haverkamp, Andreas Engert, et al.. (2005). Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin’s lymphoma—a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group. International Journal of Radiation Oncology*Biology*Physics. 63(3). 860–865.
16.
Klimm, Beate, Andreas Engert, Corinne Brillant, et al.. (2005). Comparison of BEACOPP and ABVD chemotherapy in intermediate stage Hodgkin’s lymphoma: Results of the fourth interim analysis of the HD 11 trial of the GHSG. Journal of Clinical Oncology. 23(16_suppl). 6507–6507.
17.
Diehl, Volker, Corinne Brillant, Andreas Engert, et al.. (2005). HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin’s lymphoma. Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG). Journal of Clinical Oncology. 23(16_suppl). 6506–6506.
18.
Diehl, Volker, Corinne Brillant, Jeremy Franklin, et al.. (2004). Beacopp Chemotherapy for Advanced Hodgkin’s Disease: Results of Further Analyses of the HD9- and HD12- Trials of the German Hodgkin Study Group (GHSG).. Blood. 104(11). 307–307.
19.
Diehl, Volker, Corinne Brillant, Andreas Engert, et al.. (2004). Reduction of Combined Modality Treatment Intensity in Early Stage Hodgkin’s Lymphoma: Interim Analysis of the HD 10 Trial of the GHSG.. Blood. 104(11). 1307–1307.
20.
Cormier, Denis, et al.. (1994). Puréed diet: prevalence and reported reasons for use in a long-term care hospital.. PubMed. 55(3). 121–4.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Paul J. Bröckelmann Breakdown of academic impact, for papers by Felicitas Hitz Breakdown of academic impact, for papers by Beate Klimm Breakdown of academic impact, for papers by Helen Goergen Breakdown of academic impact, for papers by Rachel Pearce Breakdown of academic impact, for papers by Silvia Franceschetti Breakdown of academic impact, for papers by Igor Aurer Breakdown of academic impact, for papers by Astrid Franke Breakdown of academic impact, for papers by Marina Djurfeldt Breakdown of academic impact, for papers by B. Lathan